CS
VSTM icon

Candriam SCA’s Verastem VSTM Stock Holding History

Candriam SCA’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-14,583
Closed -$1.32M – 647
2015
Q2 		$1.32M Sell
14,583
-2,084
-13% -$220K 0.03% 409
2015
Q1 		$2.03M Buy
16,667
+9,167
+122% +$961K 0.04% 383
2014
Q4 		$823K Buy
+7,500
New +$811K 0.02% 457

Other funds holding VSTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Candriam SCA's VSTM Position: Q3 2015 in Review

Candriam SCA sold out of Verastem (VSTM) in Q3 2015, closing a stake of 14,583 shares — an estimated $1.32M sold.

Candriam SCA first reported a position in VSTM in Q4 2014 and held it in 3 quarters. The position peaked at $2.03M in Q1 2015. 76 funds tracked by Wall St. Rank hold VSTM as of Q3 2015.

  • Candriam SCA reported no remaining Verastem position as of Q3 2015 after selling out during the quarter.
  • Candriam SCA sold 14,583 Verastem shares in Q3 2015, an estimated $1.32M.
  • Candriam SCA first reported a position in Verastem in Q4 2014 and held it in 3 quarters.
  • Candriam SCA's Verastem position peaked at $2.03M in Q1 2015.
  • 76 funds tracked by Wall St. Rank held Verastem as of Q3 2015.

Based on Candriam SCA's 13F filing for Q3 2015, filed 19 Oct 2015.